Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 117Triple Negative Breast Neoplasms 9Neoplasms 4Neoplasm Metastasis 4Lung Neoplasms 4HER2-positive Breast Cancer 4Prostatic Neoplasms 3Motor Activity 3Melanoma 3Inflammatory Breast Neoplasms 3Head and Neck Neoplasms 3Depression 3Colorectal Neoplasms 3Sarcoma 2Peripheral Nervous System Diseases 2Ovarian Neoplasms 2Fatigue 2Carcinoma, Ductal, Breast 2Breast Diseases 2Breast Carcinoma In Situ 2Anxiety Disorders 2Uterine Cervical Neoplasms 1Urogenital Neoplasms 1Urinary Incontinence 1To Evaluate the Effectiveness of GM1 in the Prevention of Albumin-paclitaxel Therapy Induced Peripheral Neuropathy in Breast Cancer Patients 1Smoking 1Sleepiness 1Seroma 1Recurrence 1Radiodermatitis 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2/3 × Orgasm × Breast × Clear all
NCT01724242 2017-11-28

Vaginal DHEA for Women After Breast Cancer

Hadassah Medical Organization

Phase 2/3 Withdrawn
Breast

Breast Neoplasms, Orgasm, Urinary Incontinence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡